SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001636282-24-000037
Filing Date
2024-05-09
Accepted
2024-05-09 16:08:14
Documents
76
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q syre-20240331.htm   iXBRL 10-Q 986500
2 EX-4.2 formofwarrantparapyrewarra.htm EX-4.2 98737
3 EX-10.6 wuxinovationagreement.htm EX-10.6 26851
4 EX-31.1 spyre-20240331xex311.htm EX-31.1 9600
5 EX-31.2 spyre-20240331xex312.htm EX-31.2 9609
6 EX-32.1 spyre-20240331xex321.htm EX-32.1 6318
12 syre-20240331_g1.jpg GRAPHIC 45827
13 syre-20240331_g2.jpg GRAPHIC 96696
14 syre-20240331_g3.jpg GRAPHIC 72735
15 syre-20240331_g4.jpg GRAPHIC 90532
16 syre-20240331_g5.jpg GRAPHIC 81653
  Complete submission text file 0001636282-24-000037.txt   7273553

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT syre-20240331.xsd EX-101.SCH 46456
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT syre-20240331_cal.xml EX-101.CAL 57151
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT syre-20240331_def.xml EX-101.DEF 310582
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT syre-20240331_lab.xml EX-101.LAB 600546
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT syre-20240331_pre.xml EX-101.PRE 449669
80 EXTRACTED XBRL INSTANCE DOCUMENT syre-20240331_htm.xml XML 802664
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37722 | Film No.: 24930561
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)